This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Early HIV treatment cost-effective in resource-limited settings

September 20th, 2011

In a cost-effectiveness study, Bruce R Schackman of Weill Cornell Medical College, USA and colleagues compare early versus standard antiretroviral treatment (ART) for HIV, based on randomized clinical trial data from Haiti. The study reveals that the new WHO guidelines for early ART initiation can be cost-effective in resource-poor settings, information that should help policymakers in developing countries allocate their often limited resources.

The authors say: "Financial and operational resources should be prioritized so that resource-poor countries are able to implement the new WHO guidelines, which recommend treatment for all HIV-infected patients with CD4 cell counts 350 cells/mm3."

More information:
Koenig SP, Bang H, Severe P, Jean Juste MA, Ambroise A, et al. (2011) Cost-Effectiveness of Early Versus Standard Antiretroviral Therapy in HIV-Infected Adults in Haiti. PLoS Med 8(9): e1001095. doi:10.1371/journal.pmed.1001095

Provided by Public Library of Science

Citation: Early HIV treatment cost-effective in resource-limited settings (2011, September 20) retrieved 11 August 2026 from https://sciencex.com/wire-news/77996338/early-hiv-treatment-cost-effective-in-resource-limited-settings.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.